Chemotherapy dose standardisation: Key therapeutic topic [KTT22]
This document summarises the evidence-base on chemotherapy dose standardisation. It is a key therapeutic topic which has been identified to support medicines optimisation. It is not formal NICE guidance.
https://www.nice.org.uk/advice/ktt22
Thanks to all the BOPA members who have contributed to the implementation support documents.
Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE: Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…
We are delighted to see the Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway today. This curriculum is the product of a truly collaborative effort across…
Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…
Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
